Capture of platelets to the endothelium of the femoral vein is mediated by CD62P and CD162

References

• Becker BF, Heindl B, Kupatt C, Zahler S. Endothelial function and hemostasis. Z Kardiol 2000; 89: 160–167
   PubMedGoogle Scholar
• Biedermann BC. Vascular endothelium: Checkpoint for inflammation and immunity. News Physiol Sci 2001; 16: 84–88
   PubMedGoogle Scholar
• Rongen GA, Smits P, Thien T. Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysiology and clinical implications. Neth J Med 1994; 44: 26–35
   PubMed Web of Science ®Google Scholar
• Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068–2101
   PubMed Web of Science ®Google Scholar
• Chen J, Lopez JA. Interactions of platelets with subendothelium and endothelium. Microcirculation 2005; 12: 235–246
   PubMed Web of Science ®Google Scholar
• Davis C, Fischer J, Ley K, Sarembock IJ. The role of inflammation in vascular injury and repair. J Thromb Haemost 2003; 1: 1699–1709
   PubMed Web of Science ®Google Scholar
• Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378–3384
   PubMed Web of Science ®Google Scholar
• McGregor L, Martin J, McGregor JL. Platelet-leukocyte aggregates and derived microparticles in inflammation, vascular remodelling and thrombosis. Front Biosci 2006; 11: 830–837
   PubMed Web of Science ®Google Scholar
• Furie B, Furie BC. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: Role of P-selectin and the P-selectin ligand, PSGL-1. Thromb Haemost 1995; 74: 224–227
   PubMed Web of Science ®Google Scholar
• Geng JG. Interaction of vascular endothelial cells with leukocytes, platelets and cancer cells in inflammation, thrombosis and cancer growth and metastasis. Acta Pharmacol Sin 2003; 24: 1297–1300
   PubMed Web of Science ®Google Scholar
• Vandendries ER, Furie BC, Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 2004; 92: 459–466
   PubMed Web of Science ®Google Scholar
• Andonegui G, Goyert SM, Kubes P. Lipopolysaccharide-induced leukocyte-endothelial cell interactions: A role for CD14 versus toll-like receptor 4 within microvessels. J Immunol 2002; 169: 2111–2119
   PubMed Web of Science ®Google Scholar
• Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional Toll-like receptor-4. Blood 2005; 106: 2417–2423
   PubMed Web of Science ®Google Scholar
• Kaisho T, Akira S. Critical roles of Toll-like receptors in host defense. Crit Rev Immunol 2000; 20: 393–405
   PubMed Web of Science ®Google Scholar
• Slotta JE, Braun OO, Menger MD, Thorlacius H. Central role of rho kinase in lipopolysaccharide-induced platelet capture on venous endothelium. J Investig Med 2008; 56: 720–725
   PubMed Web of Science ®Google Scholar
• Uhing RJ, Adams DO. Molecular events in the activation of murine macrophages. Agents Actions 1989; 26: 9–14
   PubMedGoogle Scholar
• Sester DP, Stacey KJ, Sweet MJ, Beasley SJ, Cronau SL, Hume DA. The actions of bacterial DNA on murine macrophages. J Leukoc Biol 1999; 66: 542–548
   PubMed Web of Science ®Google Scholar
• Lien E. Ingalls RR. Toll-like receptors. Crit Care Med 2002; 30(1 Supp)S1–S11
   PubMedGoogle Scholar
• Slotta JE, Braun OO, Menger MD, Thorlacius H. Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo. Inflamm Res 2006; 55: 364–367
   PubMed Web of Science ®Google Scholar
• Eriksson EE, Karlof E, Lundmark K, Rotzius P, Hedin U, Xie X. Powerful inflammatory properties of large vein endothelium in vivo. Arterioscler Thromb Vasc Biol 2005; 25: 723–728
   PubMed Web of Science ®Google Scholar
• Hanley W, McCarty O, Jadhav S, Tseng Y, Wirtz D, Konstantopoulos K. Single molecule characterization of P-selectin/ligand binding. J Biol Chem 2003; 278: 10556–10561
   PubMed Web of Science ®Google Scholar
• Croce K, Freedman SJ, Furie BC, Furie B. Interaction between soluble P-selectin and soluble P-selectin glycoprotein ligand 1: Equilibrium binding analysis. Biochemistry 1998; 37: 16472–16480
   PubMed Web of Science ®Google Scholar
• Klintman D, Li X, Thorlacius H. Important role of P-selectin for leukocyte recruitment, hepatocellular injury, and apoptosis in endotoxemic mice. Clin Diagn Lab Immunol 2004; 11: 56–62
   PubMedGoogle Scholar
• Tailor A, Cooper D, Granger DN. Platelet-vessel wall interactions in the microcirculation. Microcirculation 2005; 12: 275–285
   PubMed Web of Science ®Google Scholar
• Muller AM, Hermanns MI, Cronen C, Kirkpatrick CJ. Comparative study of adhesion molecule expression in cultured human macro- and microvascular endothelial cells. Exp Mol Pathol 2002; 73: 171–180
   PubMed Web of Science ®Google Scholar
• Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, López JA. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999; 190: 803–814
   PubMed Web of Science ®Google Scholar
• Kyrle PA, Hron G, Eichinger S, Wagner O. Circulating P-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost 2007; 97: 880–883
   PubMed Web of Science ®Google Scholar
• Blann AD, Noteboom WM, Rosendaal FR. Increased soluble P-selectin levels following deep venous thrombosis: Cause or effect?. Br J Haematol 2000; 108: 191–193
   PubMed Web of Science ®Google Scholar
• Rectenwald JE, Myers DD, Jr, Hawley AE, Longo C, Henke PK, Guire KE, Schmaier AH, Wakefield TW. D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost 2005; 94: 1312–1317
   PubMed Web of Science ®Google Scholar
• Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, Fowlkes JB, Hulin MS, Kadell AM, Wilke CA, Brown SL, et al. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 1997; 25: 816–828
   PubMed Web of Science ®Google Scholar